Your browser doesn't support javascript.
loading
Association between amyloid-beta deposition and cortical thickness in dementia with Lewy bodies.
Chin, Kai Sin; Gajamange, Sanuji; Desmond, Patricia M; Villemagne, Victor L; Rowe, Christopher C; Churilov, Leonid; Yassi, Nawaf; Watson, Rosie.
Affiliation
  • Chin KS; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.
  • Gajamange S; Department of Aged Care, The Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Desmond PM; Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Villemagne VL; Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Rowe CC; Department of Radiology, The Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.
  • Churilov L; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
  • Yassi N; Department of Molecular Imaging & Therapy, Austin Health, The University of Melbourne, Heidelberg, VIC, Australia.
  • Watson R; Department of Molecular Imaging & Therapy, Austin Health, The University of Melbourne, Heidelberg, VIC, Australia.
Aust N Z J Psychiatry ; 57(4): 594-602, 2023 04.
Article in En | MEDLINE | ID: mdl-35196886
OBJECTIVE: Amyloid-beta often co-exists in dementia with Lewy bodies, but its clinical relevance in dementia with Lewy bodies remains unclear. This study aimed to investigate the clinical and imaging correlates of amyloid-beta deposition in dementia with Lewy bodies, particularly its relationship with cortical thickness in Alzheimer's disease-prone regions and hippocampal volume. METHODS: Twenty-four participants with probable dementia with Lewy bodies underwent high-resolution magnetic resonance imaging and amyloid-beta positron emission tomography imaging using the radiotracer 18F-NAV4694. Amyloid-beta deposition was quantified and reported using the Centiloid method. RESULTS: Amyloid-beta positivity, defined as Centiloid > 50, was present in 45.8% of dementia with Lewy bodies participants. There were no statistically significant differences in clinical characteristics between Aß+ and Aß- dementia with Lewy bodies. Compared with the Aß- group, Aß+ dementia with Lewy bodies exhibited greater global cortical thinning as well as in the Alzheimer's disease-prone region of interest, adjusted for age, sex and years of education. A mean cortical thickness of 5.12 mm across a combined meta-region of interest has a sensitivity of 88.9% and specificity of 90.0% in discriminating Aß+ from Aß- dementia with Lewy bodies. Hippocampal volume was not different between groups. CONCLUSION: Early structural changes in cortical thickness, but not hippocampal volume, were observed in dementia with Lewy bodies with significant amyloid-beta burden. This may represent an early Alzheimer's disease-related neurodegenerative process.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lewy Body Disease / Alzheimer Disease Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Aust N Z J Psychiatry Year: 2023 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lewy Body Disease / Alzheimer Disease Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Aust N Z J Psychiatry Year: 2023 Document type: Article Affiliation country: Australia Country of publication: United kingdom